Abstract
Nocturia is a common symptom in the elderly and is associated with sleep fragmentation, irregular heartbeats, diabetes and stroke. It may be associated with obstructive sleep apnea-Hypopnea syndrome (OSAHS), and when present is seen more often in patients less than 50 years of age. OSAHS is often overlooked as a cause of nocturia, especially in the presence of coexisting diseases such as diabetes. OSAHS patients with frequent nocturia have higher body mass index (BMI), greater apnea-hypopnea index (AHI), and worse quality of life. Nocturia is correlated with the severity of OSAHS and the use of continuous positive airway pressure (CPAP) has shown to be beneficial. In this review, we discuss the various pathophysiologic mechanisms, clinical features and treatment options for patients with nocturia and obstructive sleep apnea-Hypopnea Syndrome.
Keywords: Aldostorone, atrial natriuretic peptide, BIPAP, CPAP, nocturia, obstructive sleep apnea-hypopnea syndrome, sympathetic surge.
Current Respiratory Medicine Reviews
Title:Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom
Volume: 9 Issue: 3
Author(s): Guy Aristide, Michael Weinstein and Girish B. Nair
Affiliation:
Keywords: Aldostorone, atrial natriuretic peptide, BIPAP, CPAP, nocturia, obstructive sleep apnea-hypopnea syndrome, sympathetic surge.
Abstract: Nocturia is a common symptom in the elderly and is associated with sleep fragmentation, irregular heartbeats, diabetes and stroke. It may be associated with obstructive sleep apnea-Hypopnea syndrome (OSAHS), and when present is seen more often in patients less than 50 years of age. OSAHS is often overlooked as a cause of nocturia, especially in the presence of coexisting diseases such as diabetes. OSAHS patients with frequent nocturia have higher body mass index (BMI), greater apnea-hypopnea index (AHI), and worse quality of life. Nocturia is correlated with the severity of OSAHS and the use of continuous positive airway pressure (CPAP) has shown to be beneficial. In this review, we discuss the various pathophysiologic mechanisms, clinical features and treatment options for patients with nocturia and obstructive sleep apnea-Hypopnea Syndrome.
Export Options
About this article
Cite this article as:
Aristide Guy, Weinstein Michael and Nair B. Girish, Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom, Current Respiratory Medicine Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573398X113099990019
DOI https://dx.doi.org/10.2174/1573398X113099990019 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Utility of the Electrocardiogram in Drug Overdose and Poisoning: Theoretical Considerations and Clinical Implications
Current Cardiology Reviews Protein Profile Analysis of Two Australian Snake Venoms by One- Dimensional Gel Electrophoresis and MS/MS Experiments
Current Medicinal Chemistry Insights into the Structure, Function, and Regulation of Human Cytochrome P450 1A2
Current Drug Metabolism Invasive Aspergillosis in Children and Adolescents
Current Pharmaceutical Design Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations
Current Pharmaceutical Biotechnology Implications of Angiotensin II in Central Nervous System on Exercise Performance
Current Protein & Peptide Science Treatment of Pulmonary Thromboembolism in Patients with Systemic Blood Pressure Stability and Right Ventricular Dysfunction
Current Respiratory Medicine Reviews Cardiotoxicity of 5-Fluorouracil
Cardiovascular & Hematological Agents in Medicinal Chemistry Discovery of an Unexplored Protein Structural Scaffold of Serine Protease from Big Blue Octopus (Octopus cyanea): A New Prospective Lead Molecule
Current Drug Discovery Technologies Nicotine and Nicotinic Receptor Involvement in Neuropsychiatric Disorders
Current Topics in Medicinal Chemistry Editorial: Perioperative Pharmacological Management: From Prescription Medications to Dietary Supplements
Current Clinical Pharmacology Interleukin 2 in Cancer Therapy
Current Medicinal Chemistry The ONTARGET Trial Programme: Facts and Lessons
Current Hypertension Reviews Dissections of the Thoracic Aorta and Evolving Endovascular Strategies
Current Hypertension Reviews Use of Cocktail Probe Drugs for Indexing Cytochrome P450 Enzymes in Clinical Pharmacology Studies – Review of Case Studies
Drug Metabolism Letters Surviving Sepsis Campaign: A Project to Change Sepsis Trajectory
Endocrine, Metabolic & Immune Disorders - Drug Targets Immunotherapy for Food Allergies in Children
Current Pharmaceutical Design Drug Delivery Systems with Modified Release for Systemic and Biophase Bioavailability
Current Clinical Pharmacology The Medicinal Chemistry of Genus <i>Aralia</i>
Current Topics in Medicinal Chemistry Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders